| HOME >> MEDICINE >> TECHNOLOGY |
FRANKFURT, Germany (PRWEB) May 21, 2020
Today Anyblock Analytics, a German firm noted for its enterprise blockchain expertise, announced the launch of the Corona SeroStatus app. Many facilities, cities, states/provinces, and countries are eager to begin re-opening their economies. Yet with more than 4.7 million confirmed cases of coronavirus globally—including nearly 1.5 million in the United States alone—serious concerns remain about how to do so safely. The SeroStatus app offers a solution that’s easy to use and which avoids the pitfalls of cybersecurity and data privacy issues with contact tracing apps and central databases.
“As stay-at-home restrictions start to relax and businesses start to re-open, there’s a lot of concern about how to be smart about it, so that we don’t see a new spike in coronavirus cases,” explained Jens Griesing, co-founder of the SeroStatus app. “Unlike contact tracing that attempts to notify individuals if they might have been exposed to coronavirus from a person who tested positive, the SeroStatus app tells who does or doesn’t pose a risk based on actual test results. And we do this while protecting individuals’ data privacy.”
Using the SeroStatus app is simple—if you know how to take a selfie and scan a QR code, you can use the app. Here’s how it works:
- First, a user takes a selfie or scans a photo ID.
- Second, the user visits an approved medical professional. The medical professional can thus confirm that the person in the phone’s app and the person in front of them are one and the same.
- Next, the user takes the chosen medical test, such as a coronavirus rapid test or an antibody test.
- Once the test results come in, the medical professional enters the result into their app and securely transfers it to the user via a unique QR code. Now the test results ‘lives’ on the user’s phone, not in a central database.
- Finally, venues can screen individuals and admit or deny entry. The venue scans the user’s QR code and sees the result, without accessing the user’s private information.
The versatile app can document who’s healthy (such as via a negative rapid test) as well as who’s recovered from previous exposure (via a positive antibody test). This is crucial information for intelligently reopening businesses, venues, and services, including:
- Hospitals and other healthcare facilities concerned about employees and visitors,
- Major office buildings with hundreds or even thousands of employees,
- Meat-packing plants, factories, and other industrial facilities, and
- Casinos, conference hotels, sporting arenas and stadiums, and other large event venues
Just as importantly, the SeroStatus app does this with a decentralized approach—in part using blockchain technology—that protects user data. Approved medical professionals attest users’ results, which are securely stored on a person’s mobile phone without a central cloud database that could be manipulated or hacked. Venues scan a user’s phone to confirm the results and approve or deny entry, without the user ever having to compromise sensitive personal information. This is another key distinction between the SeroStatus app and other approaches that use a central or even government-controlled database. With SeroStatus, everyone is in charge of their own data, while keeping that data accurate so venues can be confident in the results.
For more details on the investment opportunity or to find out how to roll this out in your region, please visit https://www.serostatus.com/ or learn more in our explainer videos.
About Anyblock Analytics
Anyblock Analytics GmbH is a German blockchain solution provider with the mission to build bridges between different organizations, across various blockchain networks and most importantly between people. Anyblocks Analytics GmbH offers methods, tools and data to integrate business processes with blockchain. The solution portfolio comprises a complete set of products and services for enterprise blockchain use cases on both public and private consortia chains.
Contact
Nicole Arnone
+1.770.856.7185 | nicolearnone@inflectionpointagency.com
Read the full story at https://www.prweb.com/releases/corona_serostatus_app_launches_leverages_blockchain_and_testing_to_offer_a_pathway_to_reopen_economies_while_protecting_user_privacy/prweb17139698.htm.
'/>"/>
| Source: PRWeb Copyright©2020 Vocus, Inc. All rights reserved |
Related medicine technology :
1. OrbusNeich Launches Worlds First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents
2. Mature US and European coronary artery bypass graft device markets will Shrink through 2021
3. Global Coronary Stents - Market Growth Analysis, 2009-2015
4. Northwestern Medicine Researchers Investigate New Stent Technology to Treat Coronary Artery Disease
5. EECP Therapy Receives Class lla Recommendation in European Society of Cardiology Guidelines for the Management of Stable Coronary Artery Disease
6. The Medicines Companys Cangrelor - Is it better than Plavix for Acute Coronary Syndrome?
7. The Acute Coronary Syndrome 12-Month Posthospital Market Will Double by 2022, Driven by the Uptake of Novel Lipid Modifying Agents
8. Global Coronary Stents Market 2014-2018: Key Vendors are Abbott, Boston Scientific, Medtronic and Terumo
9. Cangrelor Acute Coronary Syndrome Industry (Antithrombotics, Antihypertensives & Statins) Analysis & Forecasts to 2023
10. Brilinta (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023
11. PharmaPoint: Acute Coronary Syndrome - Japan Drug Forecast and Market Analysis to 2023
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |